Rhythm Pharmaceuticals
Price & Volume
Stats
See moreOpen | $53.24 |
Previous Close | $52.99 |
Day Range | $52.46-$53.24 |
52W Range | $26.55-$55.64 |
Market Cap | $3.2B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $101.7M |
Revenue Growth (YoY) | 51.3% |
Gross Profit (12 Mos) | $21.5M |
Diluted EPS | -$4.71 |
News
See moreYahoo Finance • last month
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
Yahoo Finance • 2 months ago
RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc
Yahoo Finance • 6 months ago
Rhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
Yahoo Finance • 6 months ago
Jim Cramer Portfolio: 11 Latest Stocks to Buy
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 226 |
